Selected publications from PubMed
Preoperative swallowing muscle mass is associated with 1-year skeletal muscle loss and subsequent survival in lung cancer.
Noguchi M, Higashimoto Y, Ujiie H, Takemoto T, Shiraishi M, Mizusawa H, Kanki K, Masuda A, Natsume H, Matsuzawa R, Tamaki A, Tsutani Y
Clin Nutr. 2026 Sep;64:106728 doi: 10.1016/j.clnu.2026.106728.
Adjuvant chemotherapy intensity and prognosis in completely resected high-grade neuroendocrine lung carcinoma: a post hoc analysis of JCOG1205/1206.
Isaka T, Kenmotsu H, Wakabayashi M, Yoshioka H, Shimada Y, Tsutani Y, Nakagawa K, Yotsukura M, Mitome N, Uozumi T, Daga H, Tanaka H, Kasai T, Niho S, Tsuboi M, Fukuda H, Aokage K, Okamoto I, Watanabe SI, Japan Clinical Oncology Group JCOG
Lung Cancer. 2026 Sep;219:109520 doi: 10.1016/j.lungcan.2026.109520.
The Hisashi technique: Making a "pent roof" for safe and curative lung segmentectomy.
Ujiie H, Ito M, Oiki H, Fukuda S, Nishina M, Ohara S, Nishino M, Hamada A, Chiba M, Takemoto T, Tsutani Y
JTCVS Tech. 2026 Aug;38:102482 doi: 10.1016/j.xjtc.2026.102482.
Precision Oncology in Thymic Epithelial Tumors: Therapeutic Horizons and Implementation Barriers.
Canaslan K, Yetginoğlu Ö, Tsutani Y, Sharma A, Mansila DE, Emami A, Abolhassani H, Ardeshir-Larijani F
Int J Mol Sci. 2026 Jul 24;27(15) doi: 10.3390/ijms27156613.
Oncologic Safety of Omitting Mediastinal Lymph Node Dissection in Segmentectomy for Ground-Glass Opacity-Dominant Lung Cancer: A Supplementary Analysis of JCOG1211.
Onodera K, Aokage K, Saji H, Wakabayashi M, Endo M, Tsutani Y, Nakagawa K, Shimada Y, Isaka T, Isaka M, Nakajima R, Hattori A, Maniwa T, Mimae T, Miyoshi T, Yoshioka H, Yotsukura M, Mitome N, Uozumi T, Fukuda H, Watanabe SI, Suzuki K
Eur J Cardiothorac Surg. 2026 Jun 4;68(6) doi: 10.1093/ejcts/ezag184.
The optimal surgical approach for early-stage peripheral non-small cell lung cancer is a topic of significant clinical debate. While lobectomy has long been the standard of care, recent evidence from two landmark clinical trials, JCOG0802/WJOG4607L and CALGB140503, is challenging traditional practices and refining the role of sublobar resection. Establishing clear indications for less invasive, lung-sparing procedures like segmentectomy and partial resection is essential for improving patient outcomes in thoracic surgery.The optimal surgical approach for early-stage peripheral non-small cell lung cancer is a topic of significant clinical debate. While lobectomy has long been the standard of care, recent evidence from two landmark clinical trials, JCOG0802/WJOG4607L and CALGB140503, is challenging traditional practices and refining the role of sublobar resection. Establishing clear indications for less invasive, lung-sparing procedures like segmentectomy and partial resection is essential for improving patient outcomes in thoracic surgery.
With Johnson & Johnson MedTech
Published
Oct 2025
For many years, lobectomy has been considered the gold standard oncologic resection for non-small cell lung cancer (NSCLC). However, as technology advances and a deeper understanding of segmental anatomy, segmentectomy has gained attention as a viable alternative. This less invasive option has shown promising results, although the oncologic equivalency between these techniques still remains under investigation. This event will bring together the two perspectives on this critical topic. On one hand, one of the pioneering countries of the practice and adoption of segmentectomy, Japan. On the other hand, the defending viewpoint of lobectomy over segmentectomy from a leading expert in Europe.
With Johnson & Johnson MedTech
Published
Oct 2024
Help your network discover Prof. Yasuhiro Tsutani's clinical expertise.
